INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
PK

Parmar Kush

DirectorCIK 0001664281

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score24
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
PK
Parmar KushDirector
TRDAEntrada Therapeutics, Inc.
Open-market sale
SELL$358K
52.3K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Entrada Therapeutics, Inc.Director · Aug 10, 2026
23
PK
Parmar KushDirector
TRDAEntrada Therapeutics, Inc.
Open-market sale
SELL
$647K
92.4K sh
Aug 10, 2026
Aug 10, 2026
traded Aug 10, 2026
+0d
SEC FORM 4

Evidence

24
PK
Parmar KushDirector
TRDAEntrada Therapeutics, Inc.
Open-market sale
SELL$73K
10.5K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC FORM 4

Evidence